Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Use of xenogeneic islets in hybrid artificial pancreas for treatment of diabetes without immunosuppression.

Use of xenogeneic islets in hybrid artificial pancreas for treatment of diabetes without immunosuppression. Transplant Proc. 1992 Apr; 24(2):661-2.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.